A phase II, multicentre, clinical study evaluating the safety and efficacy of Treosulfan-based conditioning of allogenic transplantation of haemopoietic stem-cells in patients affected by Thalassemia Major

Registry ID

EUCTR2005-005913-40

Source registry

EUCTR

Status

Ongoing

Phase

PHASE2

Sponsor

OSPEDALE POLICLINICO S. MATTEO

Start date

2006-01-17

Last update

2026-08-16

Conditions

• Thalassemia Major

Summary

to evaluate the safety and efficacy of Treosulfan-based conditioning of allogenic transplantation of haemopoietic stem-cells in patients affected by Thalassemia Major

Locations

• , , Italy

Related clinical trials

• Effect of Incentive Respiratory Training on Pulmonary Functions and Functional Capacity in Children With B-thalassemia Major
• Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia

View on source registry